Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

How does Jeff Galvin, CEO of Addimmune, THINK?

Aug 7, 2023

Jeff Galvin Is Taking a New Approach to Medicine There’s a revolution brewing in medicine, and the paradigm-shifting innovations in the gene and cell therapy space are right at the heart of the movement. Jeff Galvin, CEO of American Gene Technologies® (AGT ™) and Addimmune™, has seen firsthand…

Read More
Why Is It So Difficult to Find an HIV Cure?

Why Is It So Difficult to Find an HIV Cure?

Jul 5, 2023

The silent HIV epidemic has been ongoing for 4 decades. AIDS-related illnesses have claimed over 32 million lives since the beginning of the HIV epidemic in 1981. The death toll, societal impact, and economic effects of the HIV epidemic have made HIV/AIDS one of the…

Read More

How to Design a Gene Therapy to Target Cancer

Jun 21, 2023

Contributing Author Luke Williams, Sales and Marketing  The cure for cancer is the holy grail of the medical sciences, so it may surprise you to learn that there are already two types of gene therapies that treat cancer. These cancer gene therapies are being used…

Read More

Positive Clinical Trial Results Spur American Gene Technologies® to Launch Addimmune™, a Company with One Focus: Cure HIV

Jun 9, 2023

When Jeff Galvin founded American Gene Technologies in 2008, he envisioned a future where gene therapy could be used to write disease out of the genetic code. Today, on June 9, 2023, that future just got a lot closer with three major announcements:   The…

Read More
A Noble Pursuit: Gene Therapy for Rare Disease

A Noble Pursuit: Gene Therapy for Rare Disease

May 4, 2023

Rare disease, as the name suggests, affects a small proportion of the population and appears with low prevalence. The limited number of patients impedes development of new therapies, reducing the pool of clinical trial candidates and the size of the end market. A surprising figure…

Read More
How to Design a Gene Therapy to Target Viruses

How to Design a Gene Therapy to Target Viruses

Apr 24, 2023

This is a lesson you won’t learn in school. We’re at an exciting stage in biotechnology today, on the cusp of revolutionizing how we treat some of humankind’s most deadly diseases. Read on to learn how new gene therapy techniques are ushering a new age…

Read More
Transaction Trends 2022: A Good Time to be a Private Company

Transaction Trends 2022: A Good Time to be a Private Company

Apr 4, 2023

[1] Contributing Author John Vandermosten, Senior Biotechnology Analyst After a final burst of initial public offerings (IPOs) in early 2021, times have been difficult for life sciences public equities. S&P’s small cap biotech exchange traded fund, the XBI, has declined from about 174 in February 2021…

Read More
Jeff Galvin, CEO and founder of American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has been awarded the Life Sciences Voice Top Industry Leaders Award

Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award

Mar 16, 2023

American Gene Technologies® CEO and founder Jeff Galvin was awarded the Life Sciences Voice 2023 Top Industry Leaders Award. The annual award recognizes the most dynamic leaders in the life sciences industry, who are making the biggest impact in delivering transformation that is moving the…

Read More
HIV Has Been Cured For a 5th Time, Now Researchers Are Developing Scalable Methods

HIV Has Been Cured For a 5th Time, Now Researchers Are Developing Scalable Methods

Mar 6, 2023

Contributing Author Luke Williams, Sales and Marketing  A mounting body of evidence shows that HIV, once thought to be an incurable lifelong condition, is indeed curable. The “Dusseldorf Patient” made headlines recently when a stem cell transplant to treat life-threatening cancer also cured him of…

Read More

The Future is Written by Female Scientists – In Genetic Code

Mar 1, 2023

Contributing Author Luke Williams, Sales and Marketing  Our world has been revolutionized by biotechnologies like CRISPR-based gene editing and mRNA vaccines. This vigorous advancement has been powered by female scientists, and the results have reshaped industries from medicine to agriculture. The biological and biomedical sciences…

Read More

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!

Blog Categories

Follow AGT on Social Media

AGT on Facebook

Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/#genetherapy #biotech #innovation ... See MoreSee Less
View on Facebook
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook